K. Anzai et al., PRODUCTION OF ANTICARDIOLIPIN ANTIBODY IN AKR J MICE WITH STREPTOZOCIN-INDUCED INSULITIS AND DIABETES/, Diabetes research and clinical practice, 20(1), 1993, pp. 29-37
We herein report that anti-cardiolipin antibodies (ACA) were detected
in AKR/J mice treated with multiple low doses of streptozocin (STZ)-in
duced insulitis and diabetes. Daily intraperitoneal (i.p.) injections
of 40 mg/kg body wt. of STZ for five consecutive days in the AKR/J mic
e resulted in hyperglycemia and mononuclear cell infiltrations of isle
ts (insulitis). ACA appeared on day 14, when hyperglycemia began to oc
cur, at a rate of 13.3% (4/30). The rate increased to 83.3% (25/30) on
day 21, when diabetes developed, and then fell to 10% (3/30) on day 2
8. Neither the diabetic AKR/J mice treated with a single high dose of
STZ (200 mg/kg body wt.) nor the non-diabetic insulitis free Balb/c mi
ce and B10.S(9R) mice treated with multiple low doses of STZ (40 mg/kg
body wt.) produced ACA. The IgG subclass of the ACA belonged mainly t
o IgG2a. These findings suggest that ACA are produced in association w
ith the development of insulitis, but not induced by either hyperglyce
mia or STZ.